| Katherine E Murray, MD | |
|
311 W Main St, Lewistown, MT 59457-2770 | |
| (406) 535-6545 | |
| Not Available |
| Full Name | Katherine E Murray |
|---|---|
| Gender | Female |
| Speciality | General Practice |
| Location | 311 W Main St, Lewistown, Montana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710483243 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 105183 (Montana) | Primary |
| Entity Name | Bighorn Valley Health Center Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255617130 PECOS PAC ID: 8820246077 Enrollment ID: O20120913000593 |
News Archive
Medicare is again a hot-button issue as news outlets speculate on how Republican plans to revamp the program could play into the upcoming election season.
Chlamydia trachomatis is a human pathogen that is the leading cause of bacterial sexually transmitted disease worldwide with more than 90 million new cases of genital infections occurring each year. About 70 percent of women infected with Chlamydia remain asymptomatic and these bacteria can establish chronic infections for months, or even years. Even when it causes no symptoms, Chlamydia can damage a woman's reproductive organs. In addition, standard antibacterial drugs are proving increasingly ineffective in complete eradication, as Chlamydia goes in to persistent mode, leading to asymptomatic chronic infection.
Cambridge Research Biochemicals® (CRB), a longstanding British company specialising in the synthesis of custom peptides and the generation of bespoke antibodies for pharmaceutical and medical research, today announced the release of its new DISCOVERY® Antibodies catalogue. This ties in with the three year anniversary of CRB's expansion and relocation which took place in January 2014 and secures the company's position as a key player in the life science industry as we enter 2017.
Top medical research organisations are calling on the European Union for urgent reforms to the way clinical trials are regulated across the continent.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katherine E Murray, MD 207 W Main St Ste 5, Lewistown, MT 59457-2718 Ph: (406) 535-6545 | Katherine E Murray, MD 311 W Main St, Lewistown, MT 59457-2770 Ph: (406) 535-6545 |
News Archive
Medicare is again a hot-button issue as news outlets speculate on how Republican plans to revamp the program could play into the upcoming election season.
Chlamydia trachomatis is a human pathogen that is the leading cause of bacterial sexually transmitted disease worldwide with more than 90 million new cases of genital infections occurring each year. About 70 percent of women infected with Chlamydia remain asymptomatic and these bacteria can establish chronic infections for months, or even years. Even when it causes no symptoms, Chlamydia can damage a woman's reproductive organs. In addition, standard antibacterial drugs are proving increasingly ineffective in complete eradication, as Chlamydia goes in to persistent mode, leading to asymptomatic chronic infection.
Cambridge Research Biochemicals® (CRB), a longstanding British company specialising in the synthesis of custom peptides and the generation of bespoke antibodies for pharmaceutical and medical research, today announced the release of its new DISCOVERY® Antibodies catalogue. This ties in with the three year anniversary of CRB's expansion and relocation which took place in January 2014 and secures the company's position as a key player in the life science industry as we enter 2017.
Top medical research organisations are calling on the European Union for urgent reforms to the way clinical trials are regulated across the continent.
› Verified 9 days ago